Pharmaceuticals

Global Biosimilar Growth Hormones Market 2026–2030: Forecast Insights for Business Planning

February 12, 2026February 12, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the biosimilar growth hormones market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Biosimilar Growth Hormones Market expected to reach by 2030?

The biosimilar growth hormones market has witnessed rapid expansion in recent years. This market is set to increase from $0.89 billion in 2025 to $0.98 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.1%. The expansion observed historically stems from factors such as the significant cost of branded growth hormone treatments, the rising incidence of growth hormone deficiency, an uptick in diagnoses of pediatric growth disorders, restricted access to affordable treatment choices, and the dependence on hospital-based administration.

The biosimilar growth hormones market is anticipated to experience substantial expansion over the coming years. Its valuation is projected to reach $1.46 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.5%. This projected growth during the forecast period is primarily driven by factors such as the expiration of patents for branded growth hormones, a rise in biosimilar approvals, the proliferation of self-administration treatment options, increased public understanding of growth disorders, and escalating healthcare spending in developing economies. Key trends anticipated within this period encompass the wider acceptance of affordable biosimilar growth hormones, a heightened need for both pediatric and adult growth hormone treatments, a developing inclination towards subcutaneous self-administration, the broadening reach of online pharmacies and specialized clinics, and enhanced regulatory recognition for biosimilars.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3391&type=smp

What Drivers Are Driving Adoption Within The Biosimilar Growth Hormones Market?

An increasing incidence of growth hormone deficiency among children is a key factor propelling the expansion of the global biosimilar growth hormone market. This deficiency arises from damage to either the pituitary gland or the hypothalamus, potentially stemming from an atypical development present before birth (congenital) or an event occurring during or after birth (acquired). For example, data released in September 2023 by Hormones Australia, an initiative of the Endocrine Society of Australia (ESA), a national body in Australia focused on endocrine conditions, indicates that growth hormone deficiency is projected to impact 2 to 3 out of every 10,000 individuals. Consequently, the rising population of children affected by growth deficiencies is a significant catalyst for the expansion of the biosimilar growth hormones industry.

What Segments Are Included Within The Biosimilar Growth Hormones Market?

The biosimilar growth hormones market covered in this report is segmented –

1) By Route Of Administration: Subcutaneous, Intramuscular, Oral

2) By Application: Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome, Other Applications

3) By Distribution Channel: Hospital And Retail Pharmacy, Online Pharmacy/ePharmacy, Specialty Clinics

Subsegments:

1) By Subcutaneous: Self-administration, Professional Administration

2) By Intramuscular: Pediatric Care, Adult Care

3) By Oral: Tablets, Capsules

What Trends Are Projected To Support The Growth Of The Biosimilar Growth Hormones Market?

Leading firms within the biosimilar growth hormones market are developing new human growth hormone solutions aimed at improving both the effectiveness and cost-efficiency of treatments for growth hormone deficiencies. These solutions encompass medical therapies or supplements intended to either stimulate the body’s natural human growth hormone (HGH) production or replace it, addressing issues like growth deficiencies or anti-aging needs. As an example, in June 2023, the US Food and Drug Administration (FDA) granted approval for NGENLA (somatrogon-ghla) to Pfizer Inc., a pharmaceutical company from the US, and OPKO Health Inc., a US-based healthcare firm. This product is a human growth hormone treatment administered once weekly via injection, specifically created for pediatric patients suffering from growth hormone deficiency (GHD). Such a long-acting therapy provides a substitute for daily injections, thereby potentially enhancing patient and caregiver compliance and ease of use. Its approval stemmed from clinical trials that validated its effectiveness and safety, signifying a notable progression in the field of growth hormone treatments.

Who Are The Primary Competitors In The Global Biosimilar Growth Hormones Market?

Major companies operating in the biosimilar growth hormones market are Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Dr. Reddy’s Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Biosimilar Growth Hormones Market?

North America was the largest region in the biosimilar growth hormone market in 2025. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biosimilar Growth Hormones Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3391&type=smp

Browse Through More Reports Similar to the Global Biosimilar Growth Hormones Market 2026, By The Business Research Company

Hormonal Contraceptives Market Report 2026

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report

Parathyroid Hormones Market Report 2026

https://www.thebusinessresearchcompany.com/report/parathyroid-hormones-global-market-report

Biosimilar Hormone Market Report 2026

https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795